Back to Journals » Patient Preference and Adherence » Volume 6

Corrigendum

Authors Santana L, Fontenelle LF

Received 15 February 2012

Accepted for publication 15 February 2012

Published 27 February 2012 Volume 2012:6 Pages 153—154

DOI https://doi.org/10.2147/PPA.S30896

Santana L, Fontenelle LF. A review of studies concerning treatment adherence of patients with anxiety disorders. Patient Preference and Adherence. 2011;5:427–439.

1. On page 432, row 3, column 7 of Table 4 (Mancebo et al, Cognitive predictors of adherence) should be:

Patients who reported not adhering to medication described that different factors influenced their decision, including disliking medication side effects, feeling too anxious/fearful of taking medication, and perceiving treatment as not useful. Patients who described not adhering to CBT reported a number of perceived environmental barriers, such as lack of time, no money to pay for therapy, or not having CBT available.

2. On page 438, column 1, paragraph 2 under the heading OCD should be:

Mancebo et al14 found that, of the 22 patients with OCD who did not adhere to CBT, 50% reported perceived environmental barriers, including being too busy or feeling that treatment was inconvenient, not having enough money to pay for CBT, not possessing a health insurance plan that covered CBT, and not having CBT available. Conversely, of the 46 patients with OCD who reported medication nonadherence, 78.3% described disliking side effects, 41.3% argued that they were feeling too anxious/fearful of taking medication, and 41.3% perceived treatment as not useful.

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Cognitive-behavioral therapy for body dysmorphic disorder: a review of its efficacy

Prazeres AM, Nascimento AL, Fontenelle LF

Neuropsychiatric Disease and Treatment 2013, 9:307-316

Published Date: 28 February 2013

Management of obsessive-compulsive disorder with fluvoxamine extended release

Lídia Ordacgi, Mauro V Mendlowicz, Leonardo F Fontenelle

Neuropsychiatric Disease and Treatment 2009, 5:301-308

Published Date: 26 May 2009

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010